JBJason Alan Bartos

Jason Alan Bartos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jason Alan Bartos has a total of 343 co-authors. Here are the top co-authors by number of shared publications:

  • Demetris Yannopoulos

    University of Minnesota Medical School, Department of Medicine, Division of Cardiology, Center for Resuscitation Medicine, MN, USA

    19 shared publications
  • Demetris Yannopoulos

    Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN

    17 shared publications
  • Tom P. Aufderheide

    Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee (T.P.A.).

    10 shared publications
  • Ganesh Raveendran

    Division of Cardiovascular Medicine Department of Internal Medicine University of Minnesota School of Medicine Minneapolis MN

    9 shared publications
  • Jennifer N. Rees

    Department of Medicine-Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA

    7 shared publications
  • Timothy R. Matsuura

    Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, USA

    7 shared publications

Latest Publications

  • Open Access

    Designing a Cardiac Arrest System That Includes Extracorporeal Cardiopulmonary Resuscitation: A Contemporary Review

    by Adam L. Gottula, Brian Burns, Jason A. Bartos, Brian Grunau, Alex Rosenberg, Dinis Reis Miranda, Lionel Lamhaut, Jan Bělohlávek, Demetris Yannopoulos, Mark Dennis

    Extracorporeal cardiopulmonary resuscitation for refractory out‐of‐hospital cardiac arrest is increasingly used, with survival rates up to ≈30% reported in select highly organized systems, although outcomes vary widely across programs. However, outcomes are driven largely by system performance rather than the procedure itself. To date, most literature has focused on efficacy, patient selection, and cannulation techniques, with limited emphasis on system‐level design. This narrative review synthesizes the key components required to implement an effective extracorporeal cardiopulmonary resuscitation–enabled cardiac arrest system from optimizing the existing emergency medical services, understanding the expected number and distribution of potential patients undergoing extracorporeal cardiopulmonary resuscitation, using geographic information systems to optimize system design to the value of integrated structured identification pathways, streamlined intra‐arrest transport strategies, coordinated postresuscitation care within specialized cardiac arrest centers, and cost‐effectiveness considerations.

  • Top Cited Papers
    Open Access

    Recommendations in Extracorporeal Cardiopulmonary Resuscitation Post Resuscitation Care Via An International, Modified Delphi Approach

    by Mark Dennis, Alexander Supady, Darryl Abrams, Jason Bartos, Jae-Seung Jung, Natalie Kruit, Steven Ling, Alex Rosenberg, Mark Sackley, Tommaso Scquizzato, et al.

    Background: The global adoption of extracorporeal cardiopulmonary resuscitation (ECPR) for cardiac arrest is accelerating, reflecting its potential to improve outcomes in select patient populations. Although research has increasingly focused on patient selection criteria, there remains a critical lack of evidence to guide best practices in post‐ECPR resuscitation management. This study aimed to identify key knowledge gaps and develop consensus‐based recommendations to inform clinical decision‐making in the post‐ECPR setting. Methods: An international, multidisciplinary steering committee comprising 11 ECPR experts and 1 survivor conducted a targeted literature review to identify key domains and gaps in post‐ECPR care. Experts were recruited based on field impact and snowball sampling. A modified Delphi process was used, comprising 3 survey rounds. Consensus was defined a priori as ≥70% agreement or disagreement on Likert‐scale statements. Results: A total of 53 experts were recruited, representing diverse health care professions, gender, and levels of clinical experience. Of these, 52 (98%) completed all 3 rounds of the Delphi process. Consensus was reached on 126 individual statements, which were synthesized into 42 summary position statements. These recommendations span key domains of post‐ECPR care, including system‐level considerations, hemodynamic targets and management strategies, ventilation and oxygenation protocols, anticoagulation practices, temperature regulation, complication mitigation, weaning approaches, and neuroprognostication. Conclusions: This modified Delphi study, informed by a diverse international panel, resulted in 42 consensus‐based position statements addressing key aspects of post‐ECPR care. In the absence of robust empirical evidence, these expert‐derived recommendations offer a valuable framework to support clinical decision‐making and the development of standardized post‐ECPR resuscitation protocols. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06552312.


  • Open Access

    Scientific Priorities Related to the Use of Double Sequential External Defibrillation in Patients With Refractory Cardiac Arrest: Report From a Multistakeholder Thinktank

    by Graham Nichol, Dianne L. Atkins, Rudolph W. Koster, Peter J. Kudenchuk, José G. Cabañas, Douglas F. Kupas, Remle Crowe, Fred Chapman, Jason Bartos, Charles D. Deakin, et al.

    Ventricular fibrillation (VF) is common among patients with out‐of‐hospital cardiac arrest. Cardiac arrest with VF has a more favorable prognosis than those with other rhythms, but about 25% of patients with VF are still fibrillating after 3 attempts at defibrillation. Use of 2 defibrillators close together in time, “double sequential external defibrillation” (DSED), has been proposed to treat patients who remain in VF. The DOSE VF (Defibrillation Strategies for Refractory Ventricular Fibrillation) trial enrolled patients with out‐of‐hospital cardiac arrest with refractory VF to compare DSED versus vector change defibrillation versus standard defibrillation. This trial reported a significant increase in survival with DSED and vector change. DSED was also associated with a significant increase in favorable neurologic outcome. No manual or automated defibrillator is approved for use for DSED. Clinicians can choose to use defibrillators to apply DSED off label at their discretion. But in the absence of recommendations from evidence‐based guidelines, Food and Drug Administration, manufacturers, and clinicians face uncertainty about the effectiveness of DSED, its potential disruption of cardiopulmonary resuscitation interruption or use of other effective therapies, as well as potential adverse effects on patients to whom it is applied, and damage to the defibrillator. A collaborative, precompetitive thinktank including academic clinicians and researchers, regulators, and device manufacturers participated in a daylong meeting coconvened by the American Heart Association, the Cardiac Safety Research Consortium and the Food and Drug Administration. We summarize the discussion that sought to advance the understanding of the benefits and risks associated with DSED in patients who remain in VF.


  • The Association of Time to Reperfusion With VA-ECMO With Survival of Patients Who Experience Refractory Out-of-Hospital Cardiac Arrest

    by Marinos Kosmopoulos, Despoina Koukousaki, Eleanna Yannopoulou, Pierre Spaulding Sebastian, Christopher Erik Monti, Rajat Kalra, Aaron Burnett, Charles Bruen, Peter Tanghe, Bjorn Peterson, et al.


  • Open Access

    Troponin's Twist: A Sepsis Story Beyond the Heart

    by Andrea Elliott, Laith Alhuneafat, Jason A. Bartos


  • Open Access

    International Consensus on Evidence Gaps and Research Opportunities in Extracorporeal Cardiopulmonary Resuscitation for Refractory Out‐of‐Hospital Cardiac Arrest: A Report From the National Heart, Lung, and Blood Institute Workshop

    by Laurie J. Morrison, Elizabeth A. Hunt, Brian Grunau, Thomas P. Aufderheide, Clifton Callaway, Joseph E. Tonna, Comilla Sasson, Audrey Blewer, Bryan F. McNally, Demetris Yannopoulos, et al.

    The increased accessibility of extracorporeal membrane oxygenation following the COVID‐19 pandemic and the publication of the first randomized trial of extracorporeal cardiopulmonary resuscitation (ECPR) prompted the National Heart, Lung, and Blood Institute to sponsor a workshop on ECPR. Two more randomized trials have since been published in 2022 and 2023. Based on the combined findings and review of the evidence, an international panel of authors identified gaps in science, inequities in care and diversity in outcomes, and suggested research opportunities and next steps. The science pertaining to ECPR would benefit from the United States contributing uniform data to existing registries and sharing common data with the ELSO (Extracorporeal Life Support Organization) international registry to increase the sample size for observational research. In addition, well‐designed efficacy trials, recruiting across different regions of care evaluating long‐term follow‐up, including patient reported outcomes, cost effectiveness, and equity measures, would contribute significantly to the body of science. Workshop participants defined the population of patients with out‐of‐hospital cardiac arrest most likely to benefit from ECPR. ECPR‐eligible patients include those aged 18 to 75 years functioning independently without comorbidity; before suffering a witnessed out‐of‐hospital cardiac arrest and without any obvious cause of the cardiac arrest; presenting in a shockable rhythm and transported with mechanical cardiopulmonary resuscitation to an ECPR‐capable institute within 30 minutes, which is recommended after 3 rounds of advanced life support treatment without return of spontaneous circulation. There are significant inequities in out‐of‐hospital cardiac arrest care that need to be addressed such that outcomes are optimized for each target region before implementing ECPR in a clinical or implementation trial.


  • Open Access

    Geospatial Access to Extracorporeal Membrane Oxygenation in the United States

    by Adam L. Gottula, Hannah Van Wyk, Man Qi, Melissa A. Vogelsong, Chris R. Shaw, Joseph E. Tonna, Nicholas J. Johnson, Anna Condella, Jason A. Bartos, Veronica J. Berrocal, et al.

    OBJECTIVES: To conduct a Geospatial Information System analysis of extracorporeal membrane oxygenation (ECMO) centers in the United States utilizing data from the U.S. Census Bureau to better understand access to ECMO care and identify potential disparities. DESIGN: A cross-sectional descriptive and statistical analysis of geospatial access to ECMO-capable centers in the United States, accounting for demographic variables. SETTING: The unit of analysis were U.S. Census block groups and demographic variables of interest obtained from the American Community Survey. PATIENTS: Patients accounted for in the U.S. Census data. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Sixty-seven percent of the U.S. population had direct access to ECMO-capable centers. Disparities were present, with Puerto Rico, Wyoming, North Dakota, and Alaska having no access. Poverty, increased age, and lower population density consistently correlated with limited access. We identified significant racial and ethnic disparities in the Midwest and Northeast. CONCLUSIONS: While 67% of the U.S. population had access to ECMO-capable centers by ground transportation, significant disparities in access exist. These findings emphasize the need for thoughtful implementation of ECMO systems of care to ensure equitable access. Future work should focus on developing novel systems of care that increase access utilizing advanced technology, such as aeromedical transport services.


  • Heads UP CPR: An over elevated promise

    by Adam L. Gottula, Jason A. Bartos, Cindy H. Hsu

  • Open Access

    Effects of Perfusion, Coronary Artery Disease Burden, and Revascularization in Establishing Organized Cardiac Rhythm During Extracorporeal Cardiopulmonary Resuscitation for Shockable Refractory Out‐of‐Hospital Cardiac Arrest

    by Ruben Crespo‐Diaz, Marinos Kosmopoulos, Ganesh Raveendran, Sergey Gurevich, Demetris Yannopoulos, Jason A. Bartos

    The aspects of extracorporeal cardiopulmonary resuscitation critical for reestablishing an organized rhythm and subsequent functional survival are unclear. This study characterizes the impact of reperfusion with extracorporeal membrane oxygenation (ECMO) and percutaneous coronary interventions (PCI) on achieving an organized rhythm in patients with refractory shockable out-of-hospital cardiac arrest (OHCA). Two hundred eighty-nine consecutive patients in refractory shockable OHCA were placed on ECMO followed by coronary angiogram (n=289) and PCI (n=165). Patients were grouped based on the extracorporeal cardiopulmonary resuscitation stage where a sustained organized rhythm was achieved. Survival outcomes were evaluated by using the Cerebral Performance Category. Logistic regression analysis was performed to determine the relationship between Cerebral Performance Category and timing of organized rhythm. Standard advanced cardiac life support before hospital arrival resulted in 148 of 289 (51%) patients attaining an organized rhythm while 87 of 289 (30%) achieved an organized rhythm post ECMO cannulation but before PCI, and 37 of 289 (13%) achieved an organized rhythm following PCI. Obstructive coronary artery disease was observed in 192 of 289 (66%) patients. A total of 144 of 192 (75%) patients with obstructive coronary artery disease converted to an organized rhythm before PCI and 37 of 192 (19%) following PCI. Cerebral Performance Category score 1 or 2 was significantly more likely in patients with cardiac arrest and obstructive coronary artery disease who achieved an organized rhythm before PCI (odds ratio [OR], 3.9 [95% CI, 1.2-12.0], P=0.024). Most patients undergoing extracorporeal cardiopulmonary resuscitation for refractory OHCA due to shockable rhythms achieved an organized rhythm before PCI independent of coronary artery disease burden. Also, neurologically favorable survival was more prevalent in those attaining an organized rhythm before PCI.


  • Open Access

    Bleeding and Thrombosis in Patients With Out‐of‐Hospital Ventricular Tachycardia/Ventricular Fibrillation Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation

    by Alejandra Gutierrez, Rajat Kalra, Kevin Y. Chang, Marie E. Steiner, Alexandra M. Marquez, Tamas Alexy, Andrea M. Elliott, Meagan Nowariak, Demetris Yannopoulos, Jason A. Bartos

    Background: Extracorporeal cardiopulmonary resuscitation improves outcomes after out‐of‐hospital cardiac arrest. However, bleeding and thrombosis are common complications. We aimed to describe the incidence and predictors of bleeding and thrombosis and their association with in‐hospital mortality. Methods and Results: Consecutive patients presenting with refractory ventricular tachycardia/ventricular fibrillation out‐of‐hospital cardiac arrest between December 2015 and March 2022 who met the criteria for extracorporeal cardiopulmonary resuscitation initiation at our center were included. Major bleeding was defined by the Extracorporeal Life Support Organization's criteria. Adjusted analyses were done to seek out risk factors for bleeding and thrombosis and evaluate their association with mortality. Major bleeding occurred in 135 of 200 patients (67.5%), with traumatic bleeding from cardiopulmonary resuscitation in 73 (36.5%). Baseline demographics and arrest characteristics were similar between groups. In multivariable analysis, decreasing levels of fibrinogen were independently associated with bleeding (adjusted hazard ratio [aHR], 0.98 per every 10 mg/dL rise [95% CI, 0.96–0.99]). Patients who died had a higher rate of bleeds per day (0.21 versus 0.03, P <0.001) though bleeding was not significantly associated with in‐hospital death (aHR, 0.81 [95% CI. 0.55–1.19]). A thrombotic event occurred in 23.5% (47/200) of patients. Venous thromboembolism occurred in 11% (22/200) and arterial thrombi in 15.5% (31/200). Clinical characteristics were comparable between groups. In adjusted analyses, no risk factors for thrombosis were identified. Thrombosis was not associated with in‐hospital death (aHR, 0.65 [95% CI, 0.42–1.03]). Conclusions: Bleeding is a frequent complication of extracorporeal cardiopulmonary resuscitation that is associated with decreased fibrinogen levels on admission whereas thrombosis is less common. Neither bleeding nor thrombosis was significantly associated with in‐hospital mortality.